xx xx xx
TESTBANK 2024/NEWEST UPDATE EXAM
xx xx xx xx
QUESTIONS WITH CORRECT DETAILED ANSWERS
xx xx xx xx xx
AND RATIONALES/100% VERIFIED/ALREADY
xx xx xx
GRADED A+ xx xx
A xxnurse xxis xxreviewing xxa xxnew xxprescription xxfor xxOndansetron xx4 xxmg xxPO
xx PRN xxfor xxnausea xxand xxvomiting xxfor xxa xxclient xxwho xxhas xxHyperemesis
xx Gravidarum. xxThe xxnurse xxshould xxclarify xxwhich xxof xxthe xxfollowing xxparts
xx of xxthe xxprescription xxwith xxthe xxprovider?
A.
xx Name
x .
B
xx Dosag
xx C.
xx Route
D. xxFrequency xx- xxCORRECT xxANSWER-D. xxFrequency
Rationale xx:( xxThis xxprescription xxdoes xxnot xxinclude xxthe xxtime xxor
xx frequency xxof xxmedication xxadministration. xxThe xxnurse xx must xxclarify
xx this xxwith xxthe xxprescribing xxprovide)
,A x x nurse x x is x x admitting x x a x x client x x and x x completing x x a x x preassessment
xx before xxadministering x x medications. x xWhich x x of x x the x x following x x data
xx should x x the x x nurseix nclude xxin xxthe xxpreassessment? xx(Select xxall xxthat
xx apply.)
A. Use xxof xxherbal xx teas
B. Daily xxfluid xxintake
C. Current x xhealth xx status
D. Previous xxsurgical xxhistory
E. Food xx allergies xx - x x CORRECT xx ANSWER-A. x x Use
xx of x x herbaltx eas xxC. xxCurrent xxhealth xxstatus
E. xxFood xx allergies
Rationale xx: xx(A. xxThe xxnurse xxshould xxinquire xx about xx the xxclient's xxuse xxof
xx herbal xxproducts, xxwhichxoften xxcontain xxcaffeine, xxprior xxto xxmedication
xx administration xxbecause xxcaffeine xxcan xxaffect xxmedication
xx biotransformation
C. xx The x x nurse xx should x x review x x the x x client's x x current x x health x x status
xx because x x newxprescriptions xxcan xxcause xxalterations xxin xxcurrent xxhealth
xx status
E. x x The x x nurse x x should x x inquire x x about x x food x x allergies x x during x x the x xpre-
,assessment x x toxidentify xxany xxpotential xxreactions xxor xxinteractions)
A x xnurse x x orienting x x a x xnewly x xlicensed xx nurse x xis x xreviewing x x the
xx procedure x x for xxtaking x xa x x telephone x x prescription. x x Which x x of xx the
xx following x x statements x x shouldxthe xxnurse xxidentify x xas xxan xxindication xxthat
xx the xxnewly xxlicensed xxnurse xxunderstands xxthe xxprocess?
A. x x"A xx second xxnurse x x enters x x the x xprescription x xinto x x the
xx client's xxmedical x x record." xx
B. x x "Another x x nurse xx should x x listen x x to xx the xxphonexcall."
C. x x"The x x provider x x can xx clarify x x the xxprescription x x when x xhe xx signs x x the
xx health x xrecord."
D
x . x x"I x x should x x omit x x the x x 'read x x back' x x if x x this x xis x xa x x one-time x x prescription x x-
xx CORRECT xxANSWER- xxB. xx"Another xxnurse xxshould xxlisten xxto xxthe xxphone
xx call."
Rationale xx: xx(A xxsecond xx nurse xxshould xx listen xxto xxa xx telephone xxprescription
xx to xx prevent x x errors x x inxcommunication.)
A x xprovider x xprescribes x xphenobarbital x x for x xa x xclient x xwho x x has x xa x x seizure
xx disorder.T
x he x x medication x x has xx a xxlong x x half-life x x of xx 4 x x days. xxHow xx many
xx times x xper x xday xxshould xxthe xxnurse xxexpect xxto xxadminister xxthis
xx medication?
, A.
xx One
x .
B
xx Two
x .Thre
C
D. xxFour xx- xxCORRECT xxANSWER-A. xxOne
Rationale xx: xx(Medications xxwith xxlong xxhalf-lives xxremain xxat xxtheir
xx therapeutic xxlevels xxbetweenxdoses xx for xxlong xx periods xx of xxtime. xxThe
xx nurse xxshould xxexpect xxto xxadminister xx this xxmedication xxonce xxa xxday.)
A x x staf xxf x x educator x x is x x reviewing x x medication x x dosages x x and x xfactors x x that
xx influence xxmedication x x metabolism x x with x x a x xgroup x x of x x nurses x x at x x an x x in-
service x x presentation.W
x hich xx of xxthe xxfollowing x xfactors xx should xx the x xeducator
xx include x xas xxa xxreason x x to xxadminister xxlower xxmedication x xdosages? xx(Select
xx all xxthat xxapply.)
A. Increased x x renal x x secretion
B. Increased xx medication-
metabolizinge
x nzymes xx
C. xxLiver xxfailure
D. x x Peripheral x x vascular x x disease
E. xxConcurrent x x use xx of xx medication x x the xx same xxpathway
xx metabolizes x x -xCORRECT xxANSWER-C. xxLiver xxfailure